
Health
New Brain Tumor Vaccine Shows Promise in Long-Term Study
A clinical study published in Nature reveals that a new therapeutic vaccine targeting aggressive brain tumors achieved a 66% survival rate after eight years.

A clinical study published in Nature reveals that a new therapeutic vaccine targeting aggressive brain tumors achieved a 66% survival rate after eight years.

The White House has introduced 25 new Freedom Fuel gas stations in the greater…

A Boeing 737 cargo plane operated by K2 Airways has lost contact with air…

Following a conviction for embezzlement, Marine Le Pen faces a sentence involving an electronic…